We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.

Susan C. Pannullo, M.D.

You are here

Susan Pannullo, MD

Dr. Pannullo is the Director of Neurosurgical Radiosurgery and Neuro-oncology at the Weill Cornell Brain and Spine Center. Both a neurosurgeon and a neuro-oncologist, Dr. Pannullo is board-certified in neurology and neurological surgery, is fellowship trained in neuro-oncology, and has completed specialty training in stereotactic radiosurgery. She is one of the few neurosurgeons in the world with a neurosurgical practice focused only on stereotactic radiosurgery, and one of the few neurosurgeons in the country with access to three different technologies — Novalis, Gamma Knife and CyberKnife — for stereotactic radiosurgery procedures. In addition to her clinical practice, Dr. Pannullo serves in leadership positions in several important institutional and national organizations, including the Weill Cornell Institutional Review Board, the National Brain Tumor Society, the American Association of Neurological Surgeons, and the Brain Tumor Foundation.

Read a story about one of Dr. Pannullo's patients: Saving Face

TRAINING
Dr. Pannullo received her undergraduate degree with honors in anthropology from Cornell University in 1983 and her medical degree from Cornell University Medical College in 1987. Following a medicine internship at Harvard-Beth Israel Medical Center, she completed a neurology residency at New York Hospital-Cornell Medical Center in 1991. From 1991 to 1992, Dr. Pannullo was an American Cancer Society Fellow in Neuro-oncology at Memorial Sloan Kettering Cancer Center. She then completed a second residency in neurological surgery at New York Hospital-Cornell Medical Center and Memorial Sloan-Kettering Cancer Center in 1997, becoming the program’s first female graduate.

RESEARCH
Dr. Pannullo’s research portfolio has included clinical studies at NewYork-Presbyterian/Weill Cornell Medicineand Memorial Sloan Kettering Cancer Center as well as laboratory research at the National Institutes of Health. In the laboratory, Dr. Pannullo collaborates with faculty and students in the Department of Biomedical Engineering at Cornell University’s Ithaca, New York, campus to develop novel brain tumor therapies and radiosurgical technologies.